ID: ALA3649374

Max Phase: Preclinical

Molecular Formula: C29H30Cl2FN3O6S

Molecular Weight: 638.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](NC(=O)[C@@H]1C[C@@H](S(=O)(=O)c2ccccc2Cl)CN1C(=O)C1(c2ccc(Cl)cc2F)CC1)C(=O)C(=O)NC1CC1

Standard InChI:  InChI=1S/C29H30Cl2FN3O6S/c1-2-22(25(36)27(38)33-17-8-9-17)34-26(37)23-14-18(42(40,41)24-6-4-3-5-20(24)31)15-35(23)28(39)29(11-12-29)19-10-7-16(30)13-21(19)32/h3-7,10,13,17-18,22-23H,2,8-9,11-12,14-15H2,1H3,(H,33,38)(H,34,37)/t18-,22+,23+/m1/s1

Standard InChI Key:  OQVJUAAFCYLUII-LEOXJPRUSA-N

Associated Targets(Human)

CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 638.54Molecular Weight (Monoisotopic): 637.1216AlogP: 3.35#Rotatable Bonds: 10
Polar Surface Area: 129.72Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.43CX Basic pKa: CX LogP: 3.98CX LogD: 3.98
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.38Np Likeness Score: -1.03

References

1.  (2014)  Pyrrolidine derivatives, 

Source

Source(1):